Trilogy tells market continues to meet disclosure requirements on share price fall

Trilogy International, the cosmetics brand and distributor, has told the NZX it continues to comply with the stock market's rules on continuous disclosure, following a fall in its share price. 

In a letter to Trilogy, the NZX noted that Trilogy's shares had fallen from $3.85 at the market close on Oct 25, to $3.30 in trading this morning, a fall of 55 cents or 14.3 percent. 

Lindsay Render, the Chief Financial Officer for Trilogy responded that it continues to meet its obligations. 

Shares in Trilogy reached $4.92 on Aug 16, but it has tumbled since, in a period in which it listed on the ASX and released profits guidance that underwhelmed some investors. It closed up 6 cents or 1.8 percent at $3.46 and has risen 94 percent since a year ago.

BusinessDesk.co.nz

Comments from our readers

No comments yet

Add your comment:

Your name:
Your email:	Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Anti-spam verification:

Type the text you see in the image into the field below. You are asked to do this in order to verify that this enquiry is not being performed by an automated process.

Related News:

HGH Ltd Results for the 6 months ended 1 February 2026
March 27th Morning Report
CDC investor presentation and guidance update
PFI - Potential Bond Offer by PFI
MCY - Mercury Green Bond offer - interest rate set
March 25th Morning Report
AFT - Chief Financial Officer update
KMD Brands: Response to Stokehouse transaction concept
March 24th Morning Report
MCY - Mercury launches retail Green Bond offer